Melanotan I

FDA APPROVED

Fda Approved

Skin

Melanotan I

MC1R Agonist | Photoprotection & Skin Pigmentation

Learn more

Skin

Melanotan I

Amino acid sequence

7

Amino acids

1646.85da

Molecular weight

Peptide

Type

Melanotan I (afamelanotide) is a synthetic 13-amino acid analogue of alpha-melanocyte-stimulating hormone (α-MSH) that activates the melanocortin-1 receptor (MC1R) to stimulate eumelanin production in the skin. FDA-approved under the brand name Scenesse, it is indicated to increase pain-free light exposure in adults with erythropoietic protoporphyria (EPP). It is also under investigation for vitiligo, solar urticaria, and polymorphic light eruption.

Top researched benefits

Overview of Melanotan I

Afamelanotide binds selectively to the melanocortin-1 receptor (MC1R) on melanocytes, activating adenylate cyclase and elevating intracellular cAMP, which activates protein kinase A (PKA) and CREB-mediated transcription of melanogenic enzymes including tyrosinase, resulting in increased eumelanin synthesis and photoprotective skin pigmentation independent of UV exposure.

skin health

  • Stimulates melanin for deeper, longer-lasting tans with reduced UV requirements
  • Increased melanin density provides natural UV protection and reduces sunburn
  • Promotes uniform melanin distribution minimizing patchy tanning

medical applications

  • FDA-approved indication for SCENESSE implant

Typical Dose

16mg subcutaneous implant per dose

Frequency

once every 2 months

Cycle Duration

one 6-month treatment course; implant placed every 2 months within the course

Storage

Lyophilized powder: store below -18°C, stable at room temperature for up to 3 weeks. Reconstituted solution: store at 2–8°C for up to 7 days or below -18°C for long-term; avoid freeze-thaw cycles.

Chemical Makeup

Key benefits

Significantly increases pain-free light exposure in EPP patients by stimulating photoprotective eumelanin synthesis prior to sun exposure

Reduces severity and frequency of phototoxic reactions in erythropoietic protoporphyria, as demonstrated in Phase III clinical trials

Induces UV-independent skin tanning through MC1R activation, bypassing UV-induced DNA damage associated with conventional tanning

Enhances endogenous DNA repair processes in skin cells, reducing oxidative stress from UV-induced photodamage

Community interest

This peptide is still gaining traction in the community.

MC1R Agonist | Photoprotection & Skin Pigmentation

This overview is informational and based on aggregated descriptions from studies and user reports.

Was it helpful?Yes
No

Melanotan I Molecular Information

View the scientifc details of Melanotan I.

7

Amino Acids

Melanotan I

?

?

Position 1

Asp

Asp

Position 2

His

His

Position 3

Phe

Phe

Position 4

Arg

Arg

Position 5

Trp

Trp

Position 6

Lys

Lys

Position 7

Amino acid sequence
?Position 1
Aspartic acidPosition 2
HistidinePosition 3
PhenylalaninePosition 4
ArgininePosition 5
TryptophanPosition 6
LysinePosition 7

Molecular Weight

1646.85Da

Chain Length

7Amino Acids

Type

Peptide

Melanotan I Protocols

Melanotan I (afamelanotide) is delivered subcutaneously in two distinct contexts that must not be conflated. In research settings, lyophilized powder is reconstituted and self-injected daily into abdominal fat to stimulate melanogenesis — this route is unregulated, requires multiple daily doses due to a ~1.5-hour half-life, and carries risks including diffuse hyperpigmentation and darkening of existing nevi. The FDA-approved Scenesse implant is a bioresorbable rod inserted subcutaneously near the hip by a physician every 2 months (16 mg per implant); it is approved solely for prevention of phototoxicity in adults with erythropoietic protoporphyria and has a distinct risk profile, access pathway, and monitoring requirement compared to research-grade subcutaneous injection.

GoalDosageFrequencyRoute
Achieve initial baseline skin pigmentation through daily subcutaneous dosing over 10 days11 day rangeSubQ abdomen
Sustain existing pigmentation with reduced dosing frequency after loading is complete21 week rangeSubQ abdomen
Prevent phototoxic reactions in adults with erythropoietic protoporphyria using FDA-approved Scenesse implant162 month rangeSubQ implant near hip (physician-administered)
Stimulate repigmentation of depigmented skin lesions in combination with narrowband UVB phototherapy162 month rangeSubQ implant near hip (physician-administered)
Reduce phototoxic sensitivity in adults with solar urticaria or polymorphous light eruption162 month rangeSubQ implant near hip (physician-administered)
Provide melanogenic photoprotection in organ transplant recipients at elevated skin cancer risk from UV exposure162 month rangeSubQ implant near hip (physician-administered)

Reconstitution Instructions

Materials needed:

Melanotan I lyophilized powder vial (10 mg)Bacteriostatic water for injection (2 mL per vial)Insulin syringes (0.5–1 mL, 29–31 gauge)Alcohol swabsSharps disposal container

Steps to reconstitute

  1. Remove the Melanotan I vial from refrigerator and allow it to reach room temperature for 10–15 minutes before reconstitution.
  2. Draw 2 mL of bacteriostatic water into an insulin syringe.
  3. Clean the rubber stopper of the Melanotan I vial with an alcohol swab and allow to dry.
  4. Insert the needle into the vial and slowly inject the bacteriostatic water down the inside wall of the vial — never directly onto the powder.
  5. Do not shake the vial. Gently roll it between your palms until the powder is fully dissolved.
  6. The reconstituted solution (2 mL per 10 mg vial = 5 mg/mL) should appear clear and colorless; discard if cloudy or particulate matter is visible.
  7. Store the reconstituted vial refrigerated at 2–8°C and use within 4 weeks; protect from light.
  8. Clean the injection site (lower abdomen, at least 2 inches from the navel) with an alcohol swab and allow to dry.
  9. Pinch a fold of subcutaneous fat and insert the insulin syringe at a 45-degree angle.
  10. Draw the plunger back slightly to confirm no blood return, then inject slowly and withdraw the needle.
  11. Apply gentle pressure with a clean swab after withdrawal; do not rub the site.

Melanotan I Cycle

The Melanotan I Cycle section explains how long a typical cycle lasts and what to expect during each phase. Over time, your body can become less responsive with continuous use.

Taking breaks between cycles may help maintain effectiveness and support better overall results.

Day 1-3
Possible mild nausea, facial flushing, reduced appetite
Day 3-7
Initial skin darkening, increased mole/freckle pigmentation
Week 1-2
Noticeable tanning with minimal UV exposure
Week 2-4
Peak effects, maintained pigmentation with reduced frequency

Dosing tools

Melanotan I Peptide Dosage Calculator

Calculate peptide doses with our visual syringe guide.

mg

Enter the total amount of peptide in the vial in milligrams (as stated on the label).

The dose you want to inject per administration, in mcg or mg.

1,000 mcg = 1 mg

1 mL

2 mL

3 mL

5 mL

Custom

Volume of bacteriostatic water you add to reconstitute the powder. Use BAC water for preservation.

Injection Results

Based on your vial and dilution inputs.

Melanotan I

SINGLE COMPOUND

Volume per injection

0.05

mL

Concentration

10.00

mg/mL

Doses per vial

20

doses

Total injections per vial

20 injections

How it works

Based on a 10 mg Melanotan I vial diluted with 1 mL of bacteriostatic water, each 500 mcg injection equals 0.05 mL.

1mL / 100 units

5 units

0.050 mL

Reference Guide

Dosing Cycle

Peptide
Melanotan I
Dosing
16mg subcutaneous implant per dose
Dosing Frequency
once every 2 months
Cycle Duration
one 6-month treatment course; implant placed every 2 months within the course
Storage
Lyophilized powder: store below -18°C, stable at room temperature for up to 3 weeks. Reconstituted solution: store at 2–8°C for up to 7 days or below -18°C for long-term; avoid freeze-thaw cycles.

Note: Triple agonist; microdose for fewer side effects

Reconstitution Tips

  • Use bacteriostatic water (BAC)contains 0.9% benzyl alcohol for preservation
  • Inject water slowlyaim down the vial wall, not directly onto powder
  • Never shakegently swirl or roll the vial until dissolved
  • Store properlyrefrigerate at 2-8°C after reconstitution
  • Use within 28 daysmost reconstituted peptides remain stable for about 4 weeks
  • Keep sterilealways clean vial tops with alcohol before drawing

Peptide Interactions

Research suggestions of Melanotan I interactions with other common peptides and substances.

Skin

mela

Sexual

Melanotan II

AVOID

Overlapping mechanisms; avoid combining

AVOID

Side effects

Avoid: Do not take Melanotan I with Melanotan II.

Contraindications

Stop signs

Severe nausea/vomiting lasting >24 hours

Rapid concerning mole/freckle changes

Injection site infection signs

Unusual skin reactions

Allergic reaction symptoms

Bad signs

Pre-mixed liquid solutions (degrade rapidly)Cloudy or discolored solution
Was it helpful?Yes
No

Comments

0.0

0 reviews

5

4

3

2

1

No comments yet

Be the first to share your experience. Your review helps others make more informed decisions.

Frequently asked questions

What is a peptide dosage calculator?

A peptide dosage calculator is a free tool that converts your vial size, bacteriostatic water volume, and target dose into an exact syringe draw volume. Instead of doing the reconstitution math by hand, you enter three inputs and instantly get the concentration of your solution and how many milliliters or syringeunits to draw. This calculator works for single peptide compounds and multi-peptide blends.

How do I calculate peptide dosage from a vial?

To calculate your peptide dose, divide the total peptide content of your vial in micrograms by the volume of bacteriostatic water you added in milliliters. This gives you your solution concentration in mcg/mL. Then divide your target dose by that concentration to get your draw volume. For example, a 5mg (5,000 mcg) vial reconstituted with 2mL of BAC water gives a concentration of 2,500 mcg/mL. A 250 mcg dose would require drawing 0.1mL. This calculator automates all of those steps instantly.

How much Bacteriostatic water should I add to a peptide vial?

Most people add 2mL to 3mL of bacteriostatic water per vial, but the right amount depends on the dose you want to draw and the syringe size you are using. Adding 1mL to a 5mg vial gives you a concentration of 5,000 mcg/mL, making each dose very small in volume. Adding 2mL gives you 2,500 mcg/mL, which is easier to measure on a standard insulin syringe. A general guideline is to choose a volume that puts your typical dose somewhere between 10 and 30 units on a U-100 syringe. Use the calculator above to test different water volumes and find what works for your dose.

How are peptides different from proteins?

Both are made of amino acids, but peptides are much smaller than proteins. Because of their tiny size, peptides can act like tiny messengers in the body, sending specific signals to your cells to tell them exactly what to do.​

Melanotan IResearch References

Melanotan I is a fda approved compound

3Research references

Melanotan I

Melanotan I is a fda approved compound

MT-I Photoprotection Study

Demonstrated significant photoprotection effects

n.d.

Melanocortin Receptor Binding Study

Characterized MC1R selectivity

n.d.

Pharmacokinetics Injectable MT-I

Established half-life and bioavailability parameters

n.d.

Calculate peptide dosages

Learning how to calculate a peptide dose? Use our beginner-friendly peptide dosage, blend, and accumulation calculators. Enter vial size, reconstitution volume, and target dose to get exact draw volumes instantly. No guesswork, just clear guidance that helps prevent common mistakes.